Scarica l'app Stockscreener
1.015
2.40%
-0.025
Precedente Chiudi:
$1.04
Aprire:
$1
Volume 24 ore:
739.23K
Relative Volume:
0.16
Capitalizzazione di mercato:
$146.17M
Reddito:
-
Utile/perdita netta:
$-119.76M
Rapporto P/E:
-0.7519
EPS:
-1.35
Flusso di cassa netto:
$-55.17M
1 W Prestazione:
-21.92%
1M Prestazione:
+1.50%
6M Prestazione:
+120.46%
1 anno Prestazione:
-89.04%
Intervallo 1D:
$0.96
$1.09
Intervallo di 1 settimana:
$0.96
$1.305
Portata 52W:
$0.295
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
Nome
Applied Therapeutics Inc
Settore
Industria
Telefono
212-220-9226
Indirizzo
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Confronta APLT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
1.015 | 149.77M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.45 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
631.71 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.20 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
836.24 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.55 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | Downgrade | UBS | Buy → Neutral |
| 2024-11-29 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | Iniziato | William Blair | Outperform |
| 2024-03-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-02-22 | Iniziato | Leerink Partners | Outperform |
| 2022-01-04 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-08-27 | Downgrade | Goldman | Neutral → Sell |
| 2021-06-25 | Ripresa | Goldman | Neutral |
| 2020-10-08 | Iniziato | Truist | Buy |
| 2020-04-22 | Iniziato | Goldman | Buy |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2019-06-10 | Iniziato | Citigroup | Buy |
| 2019-06-10 | Iniziato | Cowen | Outperform |
| 2019-06-10 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Applied Therapeutics Inc Borsa (APLT) Ultime notizie
Custom watchlist performance reports with Applied Therapeutics Inc.2025 Growth vs Value & Free Risk Controlled Daily Trade Plans - newser.com
Analyzing Applied Therapeutics Inc. with multi timeframe chartsJuly 2025 Trade Ideas & AI Powered Market Entry Ideas - newser.com
Does Applied Therapeutics Inc. show high probability of reboundCPI Data & Expert Approved Momentum Ideas - newser.com
Volume spikes in Applied Therapeutics Inc. stock – what they meanJuly 2025 Retail & Weekly High Return Stock Opportunities - newser.com
News impact scoring models applied to Applied Therapeutics Inc.2025 Earnings Surprises & Verified High Yield Trade Plans - newser.com
Real time alert setup for Applied Therapeutics Inc. performanceChart Signals & Daily Entry Point Alerts - newser.com
What makes Applied Therapeutics Inc. stock attractive to growth funds2025 Top Decliners & Technical Confirmation Trade Alerts - newser.com
Applied Therapeutics Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Is Applied Therapeutics Inc. (2UV) stock among top earnings playsQuarterly Growth Report & Verified Short-Term Trading Plans - newser.com
Can Applied Therapeutics Inc. (2UV) stock ride next bull market cycleJuly 2025 Intraday Action & AI Enhanced Execution Alerts - newser.com
Can Applied Therapeutics Inc. (2UV) stock double in coming yearsDividend Hike & Expert-Curated Trade Recommendations - newser.com
Can Applied Therapeutics Inc. (2UV) stock surprise markets with earnings2025 Institutional Moves & Growth Focused Investment Plans - newser.com
Can a trend reversal in Applied Therapeutics Inc. lead to recoveryJuly 2025 Breakouts & Consistent Profit Focused Trading Strategies - newser.com
Will Applied Therapeutics Inc. stock recover faster than peersQuarterly Investment Review & Free Reliable Trade Execution Plans - newser.com
Statistical indicators supporting Applied Therapeutics Inc.’s strengthWall Street Watch & Expert Curated Trade Setups - newser.com
How geopolitical tensions affect Applied Therapeutics Inc. stockTrade Risk Report & Weekly Sector Rotation Insights - newser.com
Why Applied Therapeutics Inc. (2UV) stock is a must watch tickerChart Signals & Daily Entry Point Alerts - newser.com
Applying big data sentiment scoring on Applied Therapeutics Inc.Rate Cut & High Return Trade Opportunity Guides - newser.com
Is Applied Therapeutics Inc. stock a good choice for value investorsMarket Performance Recap & Weekly Return Optimization Alerts - newser.com
Are Analysts Too Optimistic About Bajaj Consumer Care Limiteds Revenue GrowthMarket Breadth Indicators & Low Cost Trading Plans - earlytimes.in
What data driven models say about Applied Therapeutics Inc.’s futureMarket Growth Summary & Real-Time Volume Analysis - newser.com
What does recent volatility data suggest for Applied Therapeutics Inc.Entry Point & Short-Term Trading Opportunity Alerts - newser.com
Applied Therapeutics (APLT) Projected to Post Earnings on Thursday - MarketBeat
Applied Therapeutics Inc Azioni (APLT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Applied Therapeutics Inc Azioni (APLT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Funtleyder Leslie D. | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
14,502 |
6,381 |
390,459 |
| Chinoporos Constantine | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
447 |
197 |
271,436 |
| Funtleyder Leslie D. | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
22,950 |
14,000 |
404,961 |
| Perfetti Riccardo | Chief Medical Officer |
Feb 06 '25 |
Sale |
0.61 |
86,078 |
52,508 |
900,775 |
| Chinoporos Constantine | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
28,117 |
17,151 |
271,883 |
1.02%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):